SG Americas Securities’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,298
Closed -$129K 3655
2024
Q4
$129K Buy
7,298
+1,893
+35% +$35.9K ﹤0.01% 2532
2024
Q3
$124K Buy
+5,405
New +$122K ﹤0.01% 2895
2024
Q1
Sell
-3,727
Closed -$147K 3280
2023
Q4
$147K Buy
+3,727
New +$156K ﹤0.01% 2434
2023
Q2
Sell
-6,011
Closed -$262K 2885
2023
Q1
$262K Buy
+6,011
New +$265K ﹤0.01% 2216
2022
Q4
Sell
-2,641
Closed -$105K 3277
2022
Q3
$105K Buy
+2,641
New +$97.8K ﹤0.01% 2834
2021
Q4
Sell
-5,739
Closed -$242K 3670
2021
Q3
$242K Buy
+5,739
New +$289K ﹤0.01% 3098
2020
Q3
Sell
-7,890
Closed -$459K 3204
2020
Q2
$459K Buy
7,890
+3,687
+88% +$195K ﹤0.01% 2163
2020
Q1
$191K Buy
4,203
+2,542
+153% +$153K ﹤0.01% 2540
2019
Q4
$110K Sell
1,661
-804
-33% -$49.1K ﹤0.01% 2901
2019
Q3
$142K Buy
+2,465
New +$153K ﹤0.01% 2542

Other funds holding NRC

SG Americas Securities's NRC Position: Q1 2025 in Review

SG Americas Securities sold out of NRC Health Common Stock (NRC) in Q1 2025, closing a stake of 7,298 shares — an estimated $129K sold.

SG Americas Securities first reported a position in NRC in Q3 2019 and held it in 10 quarters. The position peaked at $459K in Q2 2020. 123 funds tracked by Wall St. Rank hold NRC as of Q1 2025.

  • SG Americas Securities reported no remaining NRC Health Common Stock position as of Q1 2025 after selling out during the quarter.
  • SG Americas Securities sold 7,298 NRC Health Common Stock shares in Q1 2025, an estimated $129K.
  • SG Americas Securities first reported a position in NRC Health Common Stock in Q3 2019 and held it in 10 quarters.
  • SG Americas Securities's NRC Health Common Stock position peaked at $459K in Q2 2020.
  • 123 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q1 2025.

Based on SG Americas Securities's 13F filing for Q1 2025, filed 15 Apr 2025.